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Rat brain mitochondria were found to convert 3-mercaptopyruvate o 2-mercaptoacetate in the presence 
of NAD+, coenzyme A and thiamin pyrophosphate. The overall reaction probably consists of an oxidative 
decarboxylation of 3-mercaptopyruvate with 2-mercaptoacetyl CoA as a product which is then hydrolyzed 
to 2-mercaptoacetate by acyl CoA hydrolase 
3-Mercaptopyruvate 2-Mercaptoacetate a-Ketoacid decarboxylase Acyl CoA hydrolase 
1. INTRODUCTION 
Small quantities of 2-mercaptoacetate as its 
mixed disulfKe with cysteine are excreted in nor- 
mal human urine [1] but the metabolic origin of 
2-mercaptoacetate is so far unknown. Of interest is 
that increased amounts of this compound are 
found in urine from subjects with the rare 
metabolic disorder 3-mercaptolactate cysteine 
disulfiduria [2,3], a condition caused by a deficien- 
cy of the enzyme 3-mercaptopyruvate sulfur- 
transferase [3,4]. This results in an accumulation 
of 3-mercaptopyruvate in the body of affected sub- 
jects [3] and it was consequently surmised that 
3-mercaptopyruvate is a metabolic precursor to 
2-mercaptoacetate. 
We report the conversion of 3-mercaptopyru- 
vate to 2-mercaptoacetate by rat mitochondria 
supplied with NAD+, CoA and thiamin pyrophos- 
phate (TPP) as cofactors. 
2. MATERIALS AND METHODS 
Ammonium 3-mercaptopyruvate was synthe- 
sized as in [5]. Rat brain homogenates were pre- 
pared in 0.44 M sucrose and a crude mitochondrial 
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fraction was prepared according to [6] and its pro- 
tein content determined as in [7]. The conversion 
of 3-mercaptopyruvate to 2-mercaptoacetate was 
studied under reaction conditions similar to those 
used for. the decarboxylation of 4-methylthio-2- 
oxobutyrate [8] but a lower pH had to be used as 
we found in preiiminary experiments that the spon- 
taneous decarboxylation of 3-mercaptopyruvate 
drastically increased with an increase of PH. Under 
the conditions of our assay system the spontaneous 
formation of 2-mercaptoacetate from 1 pm01 of 
3-mercaptopyruvate was about 15 nmol and the 
values presented in tables I,2 are corrected for this 
blank reaction. Our standard assay system thus 
contained 70 /tmol potassium phosphate buffer 
@H 6.9, 2pmol magnesium sulfate, 4,~mol 
NAD+, 2 rmol CoA, 0.2/rmol TPP and 1 pmol 
ammonium 3-mercaptopyruvate in a final volume 
of 2.0 ml. Incubations were performed at 37°C for 
30 min with shaking in 25ml Erlenmeyer flasks. 
The reaction was terminated by the addition of 
40 ~11 M acetic acid to give pH 5.0 and 0.10 ml of 
1.25 M methylhydroxylamine hydrochloride in 
2 M sodium acetate and the sample was incubated 
for 2 h at room temperature. By this step 3-mer- 
captopyruvate remaining in the assay was con- 
verted to the metoxime, which in contrast to the 
parent compound is stable during gas chromatog- 
Published by Elsevier Science Publkhers B. V. 
334 00145793/84/$3.00  1984 Federation of European Biochemical Societies 
Volume 176, number 2 FBBS LETTERS October 1984 
raphy [3]. The sample was then deproteinized by 
the addition of 0.5 ml of 16% trichloroacetic acid 
followed by centrifugation and a 2-ml aliquot of 
the supernatant was taken for determination of 
I-mercaptoacetate by gas chromatography as in 
f91. 
3. RESULTS AND DISCUSSION 
In preliminary experiments we studied the ability 
of certain rat tissues to form 2-mercaptoacetate 
when incubated with 3-mercaptopyruvate in 
phosphate-buffered saline. Of the tissue prepara- 
tions studied (diaphragm and slices of liver, kidney 
and brain) only brain produced significant 
amounts of 2-mercaptoacetate. Further ex- 
periments showed that brain homogenates also 
could form 2-mercaptoacetate and this reaction 
was strongly inhibited by the dithiol reagent 
phenylarsine oxide but not by the monothiol 
reagent p-chloromercuribenzoate (table 1). This 
suggested the participation of a lipoate-dependent 
decarboxylase analogous to other 2-oxoacid decar- 
boxylases [lo]. It may then be presumed that the 
decarboxylation of 3-mercaptopyruvate to 
2-mercaptoacetate r quired NAD+, CoA and TPP 
as cofactors and that the reaction occurred in the 
mitochondria. In fact, brain mitochondria were 
found to convert 3-mercaptopyruvate to 2-mer- 
captoacetate but this reaction was only moder- 
ately stimulated by these cofactors when intact 
mitochondria were used (table 2). However, 
when the mitochondrial structure was disrupted 
by freezing and thawing in the presence of the 
detergent Triton-X-100 [8] an absolute require- 
Table 1 
Formation of 2-mercaptoacetate from 3-mercaptopyru- 
vate with brain homogenate and its inhibitor with thiol 
reagents 
Inhibitora 2-Mercaptoacetate 
formed (nmol) 
None 42 
Phenylarsine oxide 0 
o-Chloromercuribenzoate 37 
a The assay contained 1 ml of a 10% brain homogenate 
and inhibitors at a final concentration of 0.1 mM 
ment for NAD+ and CoA and a moderate stimula- 
tion by TPP could be demonstrated (table 2). It 
should be noted that the treatment used for disrup- 
tion of mitochondria destroyed about 5OVo of their 
3-mercaptopyruvate decarboxylating activity. Of 
interest is that the expected product of this decar- 
boxylase is 2-mercaptoacetyl CoA and not 
2-mercaptoacetate. Unfortunately, the method 
used for the determination of 2-mercaptoacetate 
[9] required a step in which the sample is incubated 
at pH 10 with thiopropyl-Sepharose, which can be 
expected to convert 2-mercaptoacetyl CoA to 
2-mercaptoacetate [111. However, further ex- 
periments indicated that the ultimate product 
formed by the action of brain mitochondria on 
3-mercaptopyruvate was 2-mercaptoacetate and 
not its CoA ester. Thus the product, similar to 
mercaptoacetate, could be completely extracted 
from the acidified sample with ethyl acetate, 
whereas short chain acyl esters of CoA are not ex- 
tracted by this procedure. Furthermore, reduction 
of the assay mixture with borohydride prior to 
determination of mercaptoacetate, a treatment 
which should convert 2-mercaptoacetyl CoA (but 
not 2-mercaptoacetate) to 2-mercaptoethanol [ 121, 
did not decrease the yield of mercaptoacetate and 
no 2-mercaptoethanol was detected by gas 
chromatography. Nevertheless, we suggest hat the 
Table 2 
Cofactor requirements for 3-mercaptopyruvate decar- 
boxylation with brain mitochondria 
Mitochondria Cofactors 2-Mercaptoacetate 
formed (nmol) 
Intacta Complete 64 
Intact None 41 
Disruptedb Complete 36 
Disrupted - NAD+ 0 
Disrupted - CoA 0 
Disrupted - TPP 26 
* The assay contained 3.0 mg mitochondrial protein 
b The assay contained 3.8 mg mitochondrial protein 
from a mitochondrial preparation frozen and thawed 
3 times after the addition of Triton X-100 to a final 
concentration of 1%. The same amount of the original 
mitochondrial preparation formed 74 nmol Z-mercap- 
toacetate in the presence of NAD+, CoA and TPP 
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primary product formed by oxidative decarboxyla- 
tion of 3-mercaptopyruvate is 2-mercaptoacetyl 
CoA, but the latter compound is rapidly hydro- 
lyzed by the short chain acyl CoA hydrolase abun- 
dantly present in rat brain mitochondria [ 13 1. Note 
that evidence has recently been presented [14] for 
the formation of 2-mercaptoacetyl CoA from 
2-mercaptoacetate, CoA and ATP by rat liver 
mitochondria or purified acetyl CoA synthase. The 
interesting possibility that 2-mercaptoacetyl CoA 
may participate in the biosyntheses of other sulfur 
compounds should also be considered. 
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